Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Harvard Business School
Accenture
Covington
Federal Trade Commission
Moodys
Express Scripts
Johnson and Johnson
US Department of Justice

Generated: May 25, 2018

DrugPatentWatch Database Preview

RAPLON Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Raplon patents expire, and what generic alternatives are available?

Raplon is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in RAPLON is rapacuronium bromide. Additional details are available on the rapacuronium bromide profile page.
Summary for RAPLON
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 9
Patent Applications: 227
DailyMed Link:RAPLON at DailyMed
Drug patent expirations by year for RAPLON
Synonyms for RAPLON
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-acetyloxy-10,13-dimethyl-2-piperidin-1-yl-16-(1-prop-2-enylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate bromide
1-(3alpha-Acetoxy-2beta-(1-piperidinyl)-17beta-(propionyloxy)-5alpha-androsta-16beta-yl)-1-allylpiperidinium bromide
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5-(acetyloxy)-2,15-dimethyl-4-(piperidin-1-yl)-14-(propanoyloxy)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-13-yl]-1-(prop-2-en-1-yl)piperidin-1-ium bromide
1-Allyl-1-(3alpha,17beta-dihydroxy-2beta-piperidino-5alpha-androstan-16beta-yl)piperidinium bromide, 3-acetate 17-propionate
156137-99-4
65Q4QDG4KC
AC1NSKJX
AMX10209
C37H61N2O4.Br
CAS-156137-99-4
CHEMBL1200549
CS-6564
D05703
D0KD4X
DSSTox_CID_28749
DSSTox_GSID_48823
DSSTox_RID_83018
DTXSID7048823
HY-16423
LS-173498
NCGC00183839-01
Org 9487
Org-9487
Piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3-(acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
Piperidinium,1-((2-beta,3alpha,5alpha,16beta,17beta)-3-(acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidinyl)androstan-16-yl)-1-(2-propenyl)-,bromide
Rapacuronium bromide
Rapacuronium bromide (USAN/INN)
Rapacuronium bromide [USAN:INN:BAN]
Raplon (TN)
SCHEMBL41132
Tox21_113304
UNII-65Q4QDG4KC

US Patents and Regulatory Information for RAPLON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-001 Aug 18, 1999 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-002 Aug 18, 1999 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for RAPLON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-001 Aug 18, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-002 Aug 18, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
UBS
Teva
Daiichi Sankyo
Moodys
Colorcon
Medtronic
Cipla
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.